Skip to main content
SpringerLink
Log in
Book cover

Metabolic Syndrome and Diabetes pp 47–59Cite as

Medical Approaches to Weight-Centric Management of Obese Patients with Type 2 Diabetes

  • Chapter

Abstract

The traditional approach to management of type 2 diabetes has been targeting both glycemic control and associated risk factors that drive cardiovascular disease risk (blood pressure, dyslipidemia, pro-thrombotic tendency). The primary focus of this chapter is to explore the role of medical approaches (as opposed to surgical approaches) using lifestyle intervention to achieve weight management as a pathway to improving the metabolic profile, symptoms, and functionality of patients with type 2 diabetes. The chapter will review the evidence for health benefit from medically induced weight loss in persons with type 2 diabetes, and will limit its scope to interventions that use lifestyle alone, without adjunctive medications.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, Davidson MB, Einhorn D, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez G, Davidson MH, American Association of Clinical Endocrinologists. American Association of Clinical Endocrinologists’ comprehensive diabetes management algorithm 2013. Endocr Pract. 2013;19 Suppl 1:1–48.

    Article  Google Scholar 

  2. The Look AHEAD Research Group. Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials. 2003;24(5):610–28.

    Article  Google Scholar 

  3. The Look AHEAD Research Group. Baseline characteristics of the randomised cohort from the Look AHEAD (Action for Health in Diabetes) research study. Diab Vasc Dis Res. 2006;3(3):202–15.

    Article  PubMed Central  Google Scholar 

  4. The Look AHEAD Research Group. The Look AHEAD Study: a description of the lifestyle intervention and the evidence supporting it. Obesity (Silver Spring). 2006;14(5):737–52.

    Article  Google Scholar 

  5. The Look AHEAD Research Group. Eight-year weight losses with an intensive lifestyle intervention: the Look AHEAD Study. Obesity. 2014;22:5–13.

    Article  PubMed Central  Google Scholar 

  6. Guare JC, Wing RR, Grant A. Comparison of obese NIDDM and nondiabetic women: short- and long-term weight loss. Obes Res. 1995;3:329–35.

    Article  PubMed  CAS  Google Scholar 

  7. Apovian CM, Aronne LJ, Bessesen DH, et al. Pharmacologic management of obesity: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(2):342–62.

    Google Scholar 

  8. Wadden T, West D, Neiberg R, The Look AHEAD Research Group, et al. One-year weight losses in the Look AHEAD study: factors associated with success. Obesity. 2009;17(4):713–22.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Espeland M, Bray G, Neiberg R, The Look AHEAD Research Group, et al. Describing patterns of weight changes using principal components analysis: results from the Action for Health in Diabetes (Look AHEAD) research group. Ann Epidemiol. 2009;19(10):701–10.

    Article  PubMed  PubMed Central  Google Scholar 

  10. The Look AHEAD Research Group. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care. 2007;30(6):1374–83.

    Article  Google Scholar 

  11. The Look AHEAD Research Group. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four year results of the Look AHEAD trial. Arch Intern Med. 2010;170(17):1566–75.

    PubMed Central  Google Scholar 

  12. Wadden T, Neiberg R, Wing R, The Look AHEAD Research Group, et al. Four-year weight losses in the Look AHEAD study: factors associated with success. Obesity. 2011;19(10):1987–98.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Unick J, Beavers D, Jakicic J, The Look AHEAD Research Group, et al. The effectiveness of lifestyle interventions for individuals with severe obesity and type 2 diabetes: results from the Look AHEAD trial. Diabetes Care. 2011;34(10):2152–7.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Unick JL, Beavers D, Bond DS, et al. The long-term effectiveness of a lifestyle intervention in severely obese individuals. Am J Med. 2013;126:236–42.

    Article  PubMed  PubMed Central  Google Scholar 

  15. The Look AHEAD Research Group. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369:145–54.

    Article  PubMed Central  CAS  Google Scholar 

  16. Sjostrom L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307(1):56–65.

    Article  PubMed  Google Scholar 

  17. Sjostrom L, Narbro K, Sjostrom D, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741–52.

    Article  PubMed  Google Scholar 

  18. Gregg EW, Chen H, Wagenknecht LE, et al. Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA. 2012;308:2489–96.

    Article  PubMed  CAS  Google Scholar 

  19. Foster G, Sanders M, Millman R, The Sleep AHEAD Ancillary Study, et al. Obstructive sleep apnea among obese patients with type 2 diabetes. Diabetes Care. 2009;32(6):1017–9.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Kuna ST, Reboussin DM, Borradaile KE, The Sleep AHEAD Research Group of the Look AHEAD Research Group, et al. Long-term effect of weight loss on obstructive sleep apnea severity in obese patients with type 2 diabetes. Sleep. 2013;36(5):641–649A.

    PubMed  PubMed Central  Google Scholar 

  21. Lazo M, Solga S, Horska A, The Fatty Liver Subgroup of the Look AHEAD Research Group, et al. Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes. Diabetes Care. 2010;33(10):2156–63.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Crosby. Manual for the IWQOL-LITE measure. www.qualityoflifeconsulting.com. Accessed 10 Sept 2014.

  23. Williamson D, Rejeski J, Lang W, The Look AHEAD Research Group, et al. Impact of a weight management program on health-related quality of life in overweight adults with type 2 diabetes. Arch Intern Med. 2009;169(2):163–71.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–71.

    Article  PubMed  CAS  Google Scholar 

  25. Faulconbridge L, Wadden T, Rubin R, The Look AHEAD Research Group, et al. One-year changes in symptoms of depression and weight in overweight/obese individuals with type 2 diabetes in the Look AHEAD study. Obesity. 2012;20(4):783–93.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Rejeski WJ, Ip EH, Bertoni AG, et al. Lifestyle change and mobility in obese adults with type 2 diabetes. N Engl J Med. 2012;366:1209–17.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  27. Foy CG, Lewis CE, Hairston KG, The Look AHEAD Research Group, et al. Intensive lifestyle intervention improves physical function among obese adults with knee pain: findings from the Look AHEAD trial. Obesity. 2011;19:83–93. Erratum, Obesity (Silver Spring) 2011;19:233.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Phelan S, Kanaya AM, Subak LL, et al. Weight loss prevents urinary incontinence in women with type 2 diabetes: results from the Look AHEAD trial. J Urol. 2012;187:939–44.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Breyer BN, Phelan S, Hogan PE, The Look AHEAD Research Group, et al. Intensive lifestyle intervention reduces urinary incontinence in overweight/obese men with type 2 diabetes: results from the Look AHEAD trial. J Urol. 2014;192(1):144–9.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Wing R, Rosen R, Fava J, Bahnson J, et al. Effects of weight loss intervention on erectile function in older men with type 2 diabetes in the Look AHEAD trial. J Sex Med. 2010;7(1 Pt 1):156–65.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Wing RR, Bond DS, Gendrano IN, The Sexual Dysfunction Subgroup of the Look AHEAD Research Group, et al. Effect of intensive lifestyle intervention on sexual dysfunction in women with type 2 diabetes: results from an ancillary Look AHEAD study. Diab Care. 2013;36:2937–44.

    Article  Google Scholar 

  32. Espeland MA, Glick HA, Bertoni A et al., the Look AHEAD Research Group. Impact of an intensive lifestyle intervention on use and cost of medical services among overweight and obese adults with Type 2 diabetes. Diabetes Care. 2014;37(9):2548–56.

    Google Scholar 

  33. O’Neil PM, Smith SR, Weissman NJ, et al. Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study. Obesity. 2012;20(7):1426–36.

    Article  PubMed  CAS  Google Scholar 

  34. Garvey WT, Ryan DH, Bohannon NJV, et al. Weight loss therapy in type 2 diabetes: effects of phentermine and topiramate extended-release. Diabetes Care. 2014;37(12):3309–16.

    Article  PubMed  CAS  Google Scholar 

  35. Hollander P, Gupta AK, Plodkowski R, The COR-Diabetes Study Group, et al. Effects of naltrexone sustained-release/bupropion sustained-release combination therapy on body weight and glycemic parameters in overweight and obese patients with type 2 diabetes. Diabetes Care. 2013;36(12):4022–9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  36. FDA Briefing Document NDA 206321. LIraglutide 3.0 mg. Endocrinologic and Metabolic Advisory Committee. 11 Sept 2014. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM413317.pdf. Accessed 25 Sept 2014.

Download references

Author information

Authors and Affiliations

  1. Pennington Biomedical Research Center, 625 St Charles Avenue, 10B, New Orleans, LA, 70130, USA

    Donna H. Ryan M.D.

Authors
  1. Donna H. Ryan M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Donna H. Ryan M.D. .

Editor information

Editors and Affiliations

  1. Department of Surgery, NYU School of Medicine, New York, New York, USA

    Marina Kurian

  2. Department of Surgery, Oregon Health and Science University, Portland, Oregon, USA

    Bruce M. Wolfe

  3. Department of Surgery, University of Minnesota, Minneapolis, Minnesota, USA

    Sayeed Ikramuddin

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this chapter

Cite this chapter

Ryan, D.H. (2016). Medical Approaches to Weight-Centric Management of Obese Patients with Type 2 Diabetes. In: Kurian, M., Wolfe, B., Ikramuddin, S. (eds) Metabolic Syndrome and Diabetes. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-3220-7_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-3220-7_4

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-3219-1

  • Online ISBN: 978-1-4939-3220-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation